BenzamidesPiperazinesPyrimidinesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGastrointestinal Stromal TumorsFusion Proteins, bcr-ablAntineoplastic AgentsProtein Kinase InhibitorsLeukemia, Myeloid, Chronic-PhaseProto-Oncogene Proteins c-kitDrug Resistance, NeoplasmReceptor, Platelet-Derived Growth Factor alphaGenes, ablProto-Oncogene Proteins c-ablK562 CellsBlast CrisisProtein-Tyrosine KinasesThiazolesCytogenetic AnalysisGastrointestinal NeoplasmsPhiladelphia ChromosomeHypereosinophilic SyndromeLeukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeTreatment OutcomeRemission InductionOrganic Cation Transporter 1Leukemia, Myeloid, Accelerated PhaseDisease-Free SurvivalReceptors, Platelet-Derived Growth FactorHarringtoninesCell Line, TumorGene Expression Regulation, LeukemicMutationDose-Response Relationship, DrugInterferon-alphaDermatofibrosarcomaDrug Administration SchedulePrecursor Cell Lymphoblastic Leukemia-LymphomaApoptosisAntineoplastic Combined Chemotherapy ProtocolsCell ProliferationPyrrolesNeoplasm, ResidualGenes, sisEnzyme InhibitorsTreatment FailureMuscle CrampDisease ProgressionFibromatosis, AggressiveMastocytosis, SystemicTime FactorsDrug MonitoringHypopigmentationSalvage TherapyPhosphorylationSurvival AnalysisSurvival RateCytogeneticsBiomarkers, PharmacologicalDrug SynergismPrognosisCytarabineInhibitory Concentration 50Drug ApprovalIndolesProto-Oncogene Proteins c-sismRNA Cleavage and Polyadenylation FactorsReverse Transcriptase Polymerase Chain ReactionHydroxyureaAdministration, OralSignal TransductionP-GlycoproteinFollow-Up StudiesClinical Trials, Phase II as TopicRecurrenceIn Situ Hybridization, FluorescenceWithholding TreatmentDNA Mutational AnalysisNeoplastic Stem Cellssrc-Family KinasesClinical Trials as TopicPlatelet-Derived Growth FactorEarly Termination of Clinical TrialsKaplan-Meier EstimatePregnancy Complications, NeoplasticDrug InteractionsLichenoid EruptionsRNA, MessengerPapio anubisCell SurvivalOncogene Proteins v-ablNeoplasm Recurrence, LocalChordomaSTAT5 Transcription FactorTransplantation, HomologousModels, EconomicLeukemiaStem Cell FactorDrug Screening Assays, AntitumorAntigens, CD34